Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeffrey Montgomery

Concepts (434)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
52
2025
166
9.110
 Why?
Cystectomy
32
2025
52
6.060
 Why?
Prostatic Neoplasms
42
2024
398
4.670
 Why?
Kidney Neoplasms
22
2018
181
2.570
 Why?
Carcinoma, Transitional Cell
13
2023
54
2.490
 Why?
Prostatectomy
22
2023
84
2.190
 Why?
Nephrectomy
19
2016
81
1.850
 Why?
Lymph Node Excision
7
2024
133
1.700
 Why?
Urinary Diversion
6
2021
43
1.520
 Why?
Laparoscopy
13
2014
180
1.430
 Why?
Quality of Life
13
2025
893
1.390
 Why?
Prostate
13
2024
116
1.330
 Why?
Aged
80
2025
10243
1.230
 Why?
Male
119
2025
26882
1.160
 Why?
Middle Aged
86
2025
13136
1.100
 Why?
Humans
148
2025
52459
1.100
 Why?
Neoadjuvant Therapy
12
2024
124
1.060
 Why?
Neoplasm Staging
25
2024
768
0.960
 Why?
BCG Vaccine
7
2024
16
0.910
 Why?
Robotics
8
2015
43
0.900
 Why?
Postoperative Complications
15
2021
1066
0.860
 Why?
Carcinoma, Renal Cell
10
2016
112
0.840
 Why?
Retrospective Studies
51
2024
6695
0.840
 Why?
Neoplasm Recurrence, Local
15
2025
639
0.830
 Why?
Penile Neoplasms
3
2024
45
0.820
 Why?
Exercise Therapy
1
2023
101
0.760
 Why?
Ureter
3
2016
35
0.760
 Why?
Exercise
2
2023
559
0.740
 Why?
Hernia
2
2020
6
0.720
 Why?
Treatment Outcome
31
2025
5508
0.670
 Why?
Intestine, Small
2
2020
112
0.660
 Why?
Aged, 80 and over
27
2025
3450
0.640
 Why?
Physical Fitness
1
2020
56
0.640
 Why?
Herniorrhaphy
1
2020
32
0.640
 Why?
Intestinal Obstruction
1
2020
36
0.630
 Why?
Neoplasm Invasiveness
15
2025
278
0.620
 Why?
Patient Readmission
6
2021
249
0.620
 Why?
Image-Guided Biopsy
6
2024
35
0.610
 Why?
Watchful Waiting
7
2019
29
0.590
 Why?
Biopsy
17
2023
595
0.570
 Why?
Ureteral Neoplasms
2
2018
11
0.560
 Why?
Female
59
2025
28286
0.540
 Why?
Organ Sparing Treatments
5
2025
58
0.520
 Why?
Testicular Neoplasms
4
2024
46
0.520
 Why?
Magnetic Resonance Imaging
10
2023
1508
0.520
 Why?
Urinary Bladder
7
2018
101
0.510
 Why?
Prospective Studies
18
2025
2436
0.500
 Why?
Convalescence
1
2016
6
0.500
 Why?
Carcinoma, Squamous Cell
4
2024
331
0.490
 Why?
Neoplasm Grading
14
2025
127
0.480
 Why?
Neoplasms, Germ Cell and Embryonal
3
2024
20
0.470
 Why?
Urothelium
4
2018
19
0.450
 Why?
Carcinoma in Situ
4
2024
72
0.450
 Why?
Chemotherapy, Adjuvant
8
2024
122
0.450
 Why?
Ileum
1
2014
87
0.430
 Why?
Urologic Neoplasms
3
2019
12
0.430
 Why?
Choline
3
2019
64
0.420
 Why?
Medical Oncology
4
2021
97
0.420
 Why?
Quality Indicators, Health Care
1
2013
91
0.380
 Why?
Needles
3
2021
26
0.370
 Why?
Administration, Intravesical
7
2024
16
0.360
 Why?
Urologic Surgical Procedures
3
2016
30
0.360
 Why?
Disease Progression
8
2024
870
0.360
 Why?
Lymphatic Metastasis
4
2024
210
0.360
 Why?
Antineoplastic Agents
3
2021
1215
0.360
 Why?
Biopsy, Needle
5
2021
181
0.350
 Why?
Survival Rate
9
2021
944
0.350
 Why?
Prostate-Specific Antigen
8
2021
41
0.350
 Why?
Testicular Diseases
1
2011
9
0.340
 Why?
Risk Assessment
10
2019
1349
0.340
 Why?
Urogenital Neoplasms
1
2010
9
0.330
 Why?
Muscle Neoplasms
1
2010
16
0.320
 Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.320
 Why?
Registries
4
2023
639
0.310
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1020
0.310
 Why?
Fluorine Radioisotopes
2
2019
25
0.310
 Why?
Retroperitoneal Space
5
2016
25
0.310
 Why?
Recovery of Function
2
2023
201
0.300
 Why?
Adult
27
2024
14212
0.300
 Why?
Self Report
1
2010
221
0.300
 Why?
Psoas Muscles
2
2021
2
0.300
 Why?
Telomerase
2
2019
26
0.290
 Why?
Patient Selection
5
2019
269
0.280
 Why?
Urinary Incontinence
3
2023
40
0.270
 Why?
Seat Belts
2
2017
17
0.270
 Why?
Child Restraint Systems
2
2017
18
0.270
 Why?
Urinary Catheterization
1
2007
24
0.270
 Why?
Positron-Emission Tomography
2
2019
297
0.270
 Why?
Urethral Stricture
1
2007
23
0.270
 Why?
Time Factors
13
2020
2987
0.260
 Why?
Primary Health Care
1
2011
387
0.260
 Why?
Rectum
2
2024
55
0.250
 Why?
Tomography, X-Ray Computed
3
2021
1141
0.250
 Why?
Cohort Studies
8
2021
1579
0.250
 Why?
Guideline Adherence
3
2017
142
0.250
 Why?
Length of Stay
6
2020
673
0.240
 Why?
Health Status
2
2015
300
0.240
 Why?
Patient Discharge
3
2017
320
0.240
 Why?
Pain Measurement
2
2017
263
0.240
 Why?
Patient Participation
2
2016
65
0.230
 Why?
Kidney
4
2014
716
0.230
 Why?
Tumor Burden
5
2016
132
0.230
 Why?
Carcinoma
2
2018
135
0.220
 Why?
Bandages
1
2005
27
0.220
 Why?
Adenoviridae
2
2024
46
0.220
 Why?
Surgical Wound Infection
1
2005
118
0.220
 Why?
Neurilemmoma
1
2004
24
0.220
 Why?
Age Factors
7
2021
1120
0.220
 Why?
Adenocarcinoma
3
2016
403
0.220
 Why?
Multivariate Analysis
8
2016
601
0.220
 Why?
Immunohistochemistry
5
2024
977
0.220
 Why?
Quality Improvement
3
2016
226
0.220
 Why?
Venous Thrombosis
1
2005
89
0.210
 Why?
Follow-Up Studies
9
2024
2294
0.210
 Why?
Perineum
1
2024
26
0.210
 Why?
Decision Making
2
2016
273
0.200
 Why?
Antibiotic Prophylaxis
1
2024
63
0.200
 Why?
Clinical Competence
3
2016
405
0.200
 Why?
Practice Guidelines as Topic
2
2018
498
0.200
 Why?
Urethra
3
2014
97
0.190
 Why?
Erectile Dysfunction
3
2023
94
0.190
 Why?
United States
12
2020
5215
0.180
 Why?
DNA, Neoplasm
2
2018
146
0.180
 Why?
Logistic Models
7
2021
932
0.180
 Why?
Feasibility Studies
2
2020
404
0.170
 Why?
Vital Statistics
1
2021
3
0.170
 Why?
Mandatory Reporting
1
2021
12
0.170
 Why?
Death Certificates
1
2021
15
0.170
 Why?
DNA Mutational Analysis
3
2018
179
0.170
 Why?
Birth Certificates
1
2021
24
0.170
 Why?
Cost-Benefit Analysis
2
2019
271
0.170
 Why?
Cell Transdifferentiation
1
2021
8
0.170
 Why?
Neuroendocrine Cells
1
2021
9
0.170
 Why?
Reproducibility of Results
7
2018
1224
0.170
 Why?
Urethral Diseases
2
2013
7
0.170
 Why?
Prognosis
8
2021
2100
0.170
 Why?
Radiosurgery
1
2022
130
0.170
 Why?
Radiography, Abdominal
1
2020
24
0.160
 Why?
Mutation
5
2019
1331
0.160
 Why?
Reimbursement, Incentive
1
2020
12
0.160
 Why?
Genetic Vectors
1
2020
128
0.160
 Why?
Randomized Controlled Trials as Topic
4
2023
625
0.160
 Why?
Ablation Techniques
1
2019
19
0.160
 Why?
Genetic Therapy
1
2020
127
0.160
 Why?
Abdominal Pain
1
2020
83
0.150
 Why?
Diagnosis, Differential
2
2020
1029
0.150
 Why?
Venous Thromboembolism
1
2020
80
0.150
 Why?
Genetic Predisposition to Disease
5
2024
525
0.150
 Why?
Adjuvants, Immunologic
3
2024
51
0.150
 Why?
Urinary Tract
1
2018
23
0.150
 Why?
Lymphocytes
1
2019
146
0.150
 Why?
Forecasting
1
2019
151
0.150
 Why?
Predictive Value of Tests
6
2018
939
0.150
 Why?
Obesity
2
2006
1176
0.140
 Why?
Neutrophils
1
2019
148
0.140
 Why?
Patient-Centered Care
1
2020
141
0.140
 Why?
Genetic Heterogeneity
1
2018
20
0.140
 Why?
RNA, Neoplasm
1
2018
45
0.140
 Why?
Internship and Residency
2
2021
438
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2018
46
0.140
 Why?
Drug Resistance, Neoplasm
1
2020
336
0.140
 Why?
Retroperitoneal Neoplasms
1
2018
17
0.140
 Why?
Orchiectomy
1
2018
38
0.140
 Why?
Transurethral Resection of Prostate
1
2018
10
0.140
 Why?
Pain, Postoperative
2
2016
169
0.140
 Why?
Body Size
1
2017
32
0.130
 Why?
Quality Assurance, Health Care
1
2018
147
0.130
 Why?
Physician-Patient Relations
2
2016
142
0.130
 Why?
Inguinal Canal
1
2017
11
0.130
 Why?
Urodynamics
2
2014
24
0.130
 Why?
Sarcosine
1
2017
3
0.130
 Why?
Anticoagulants
1
2020
276
0.130
 Why?
Amino Acid Transport Systems
1
2017
5
0.130
 Why?
Databases, Factual
2
2021
722
0.130
 Why?
Body Height
1
2017
65
0.130
 Why?
Electronic Health Records
1
2020
274
0.130
 Why?
Safety
1
2017
78
0.130
 Why?
Carbon Radioisotopes
1
2017
54
0.130
 Why?
Guidelines as Topic
1
2017
111
0.130
 Why?
Disease-Free Survival
5
2016
461
0.130
 Why?
Transcriptome
2
2018
357
0.130
 Why?
Replantation
1
2016
11
0.130
 Why?
Scrotum
2
2015
31
0.130
 Why?
Nomograms
1
2016
7
0.120
 Why?
Protons
1
2017
74
0.120
 Why?
Laparotomy
1
2016
36
0.120
 Why?
Natural Orifice Endoscopic Surgery
1
2016
6
0.120
 Why?
Physicians
2
2016
237
0.120
 Why?
Research Report
1
2016
19
0.120
 Why?
Kaplan-Meier Estimate
5
2017
485
0.120
 Why?
Urinary Retention
2
2007
7
0.120
 Why?
Patient Preference
1
2016
43
0.120
 Why?
Ureteral Obstruction
1
2016
62
0.120
 Why?
Checklist
1
2016
39
0.120
 Why?
Time-to-Treatment
1
2016
77
0.120
 Why?
Preoperative Period
3
2021
47
0.120
 Why?
Sensitivity and Specificity
5
2018
871
0.120
 Why?
Genital Neoplasms, Male
1
2015
2
0.110
 Why?
Paget Disease, Extramammary
1
2015
5
0.110
 Why?
Social Networking
1
2015
17
0.110
 Why?
Body Weight
1
2017
524
0.110
 Why?
Lymph Nodes
1
2017
253
0.110
 Why?
Radiopharmaceuticals
1
2016
198
0.110
 Why?
Feedback
1
2015
52
0.110
 Why?
Treatment Failure
2
2017
117
0.110
 Why?
Video Recording
1
2015
79
0.110
 Why?
Informed Consent
1
2015
92
0.110
 Why?
Peer Group
1
2015
61
0.110
 Why?
Proto-Oncogene Proteins B-raf
1
2015
75
0.110
 Why?
Papilloma, Inverted
1
2014
1
0.110
 Why?
Equipment Design
3
2021
287
0.110
 Why?
Proto-Oncogene Proteins p21(ras)
1
2014
67
0.110
 Why?
Computer Simulation
1
2015
287
0.110
 Why?
Blood Loss, Surgical
5
2016
70
0.110
 Why?
Matched-Pair Analysis
1
2013
11
0.100
 Why?
Urinary Incontinence, Stress
1
2014
32
0.100
 Why?
Adenoma
1
2015
114
0.100
 Why?
Kidney Diseases
1
2016
230
0.100
 Why?
Diffusion of Innovation
1
2013
47
0.100
 Why?
Body Mass Index
3
2020
702
0.100
 Why?
Carcinoma, Papillary
1
2014
49
0.100
 Why?
General Surgery
1
2015
106
0.100
 Why?
Technology Transfer
1
2013
2
0.100
 Why?
Mitomycin
1
2013
20
0.100
 Why?
Longitudinal Studies
2
2018
758
0.100
 Why?
Radiotherapy, Adjuvant
2
2018
65
0.100
 Why?
Accreditation
1
2013
62
0.100
 Why?
Peripheral Nerves
1
2013
47
0.100
 Why?
Education, Medical, Continuing
1
2013
77
0.090
 Why?
Referral and Consultation
2
2012
288
0.090
 Why?
Operating Rooms
1
2012
27
0.090
 Why?
Community Health Centers
1
2012
30
0.090
 Why?
Pathology, Clinical
1
2012
25
0.090
 Why?
Receptors, Androgen
2
2002
48
0.090
 Why?
Algorithms
1
2015
673
0.090
 Why?
Combined Modality Therapy
3
2021
641
0.090
 Why?
Neoplasms
1
2021
1313
0.090
 Why?
Risk Factors
5
2017
3972
0.080
 Why?
Perioperative Care
1
2011
43
0.080
 Why?
Seminal Vesicles
2
2022
13
0.080
 Why?
Skin Neoplasms
1
2015
496
0.080
 Why?
Phantoms, Imaging
2
2020
118
0.080
 Why?
Multicenter Studies as Topic
2
2023
112
0.080
 Why?
Medicare
3
2020
281
0.080
 Why?
Severity of Illness Index
1
2012
1045
0.070
 Why?
Proportional Hazards Models
3
2016
446
0.070
 Why?
Markov Chains
2
2019
29
0.070
 Why?
Immunotherapy
1
2010
251
0.070
 Why?
Carboplatin
2
2022
55
0.070
 Why?
SEER Program
3
2014
105
0.070
 Why?
Postoperative Care
2
2020
104
0.070
 Why?
Healthcare Disparities
1
2011
292
0.070
 Why?
Ureteroscopy
1
2007
10
0.070
 Why?
Pandemics
2
2023
580
0.070
 Why?
Automobiles
2
2017
13
0.070
 Why?
Sarcopenia
2
2021
99
0.070
 Why?
Chi-Square Distribution
3
2013
292
0.070
 Why?
Incidence
2
2021
1097
0.070
 Why?
Diverticulum
1
2007
21
0.070
 Why?
Peritoneum
1
2007
16
0.070
 Why?
Cisplatin
2
2022
282
0.070
 Why?
Delphi Technique
2
2018
66
0.070
 Why?
Aftercare
2
2018
67
0.060
 Why?
Gene Amplification
2
2018
59
0.060
 Why?
Societies, Medical
2
2018
200
0.060
 Why?
Adrenalectomy
1
2006
33
0.060
 Why?
Promoter Regions, Genetic
2
2019
465
0.060
 Why?
Postoperative Hemorrhage
1
2006
54
0.060
 Why?
Case-Control Studies
3
2014
1201
0.060
 Why?
Fibrin Tissue Adhesive
1
2005
13
0.060
 Why?
Sex Factors
2
2020
735
0.060
 Why?
Hand
1
2005
51
0.060
 Why?
Tissue Adhesives
1
2005
15
0.060
 Why?
Genomics
2
2018
266
0.060
 Why?
Intestines
1
2006
159
0.060
 Why?
Suture Techniques
1
2005
59
0.060
 Why?
Renal Insufficiency
1
2005
109
0.060
 Why?
Diabetes Complications
1
2005
124
0.060
 Why?
Chromosomes, Human, Pair 12
1
2024
13
0.050
 Why?
Glomerular Filtration Rate
2
2016
126
0.050
 Why?
Vulnerable Populations
1
2024
51
0.050
 Why?
Superior Mesenteric Artery Syndrome
1
2004
3
0.050
 Why?
Mediastinal Neoplasms
1
2024
19
0.050
 Why?
Communication
2
2016
255
0.050
 Why?
Deoxycytidine
2
2014
24
0.050
 Why?
Hernia, Inguinal
1
2004
20
0.050
 Why?
Intraoperative Complications
1
2005
113
0.050
 Why?
Phenotype
2
2018
792
0.050
 Why?
High-Throughput Nucleotide Sequencing
2
2015
178
0.050
 Why?
Cell Line, Tumor
2
2018
1429
0.050
 Why?
Neoplasms, Second Primary
1
2024
75
0.050
 Why?
Child
3
2024
7195
0.050
 Why?
Quality of Health Care
2
2015
186
0.050
 Why?
Papillomavirus Infections
2
2015
170
0.050
 Why?
Ischemia
1
2004
150
0.050
 Why?
Perioperative Period
2
2013
21
0.050
 Why?
Trinucleotide Repeats
1
2002
4
0.050
 Why?
Liver Cirrhosis
1
2005
243
0.050
 Why?
Chromosome Aberrations
1
2024
295
0.050
 Why?
Muscles
1
2022
108
0.050
 Why?
Odds Ratio
2
2014
564
0.050
 Why?
Smoking
1
2005
514
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2002
65
0.050
 Why?
Accidents, Traffic
2
2017
91
0.040
 Why?
Gallium Isotopes
1
2021
2
0.040
 Why?
Gallium Radioisotopes
1
2021
9
0.040
 Why?
Edetic Acid
1
2021
13
0.040
 Why?
Radiotherapy, Intensity-Modulated
2
2013
184
0.040
 Why?
Androgen Antagonists
1
2021
12
0.040
 Why?
Geography
1
2021
65
0.040
 Why?
Polymorphism, Single Nucleotide
1
2024
506
0.040
 Why?
Quarantine
1
2021
11
0.040
 Why?
Public Health
1
2023
226
0.040
 Why?
Internationality
1
2021
46
0.040
 Why?
Neoplasm Metastasis
2
2017
235
0.040
 Why?
Drug Dosage Calculations
1
2020
11
0.040
 Why?
Motion
1
2020
19
0.040
 Why?
Enoxaparin
1
2020
31
0.040
 Why?
Finite Element Analysis
1
2020
11
0.040
 Why?
Fellowships and Scholarships
1
2021
123
0.040
 Why?
Drug Monitoring
1
2020
81
0.040
 Why?
Pelvis
1
2020
65
0.040
 Why?
Abdomen
1
2020
71
0.040
 Why?
DNA-Directed RNA Polymerases
1
2019
11
0.040
 Why?
Young Adult
2
2024
4349
0.040
 Why?
Heparin
1
2020
88
0.040
 Why?
Postoperative Period
1
2020
169
0.040
 Why?
Social Behavior
1
2019
74
0.040
 Why?
Urine
1
2018
26
0.040
 Why?
Adolescent
2
2024
6714
0.040
 Why?
Cytodiagnosis
1
2018
42
0.040
 Why?
Diagnostic Errors
1
2018
69
0.040
 Why?
Single-Blind Method
1
2018
118
0.030
 Why?
Image Processing, Computer-Assisted
1
2019
234
0.030
 Why?
DNA Copy Number Variations
1
2018
116
0.030
 Why?
Genome, Human
1
2018
121
0.030
 Why?
Quality-Adjusted Life Years
1
2018
67
0.030
 Why?
Sequence Analysis, RNA
1
2018
96
0.030
 Why?
Random Allocation
1
2018
286
0.030
 Why?
Hospitalization
2
2017
731
0.030
 Why?
Delivery of Health Care, Integrated
1
2018
51
0.030
 Why?
Health Services Accessibility
2
2012
444
0.030
 Why?
Dose-Response Relationship, Drug
1
2020
1365
0.030
 Why?
Nephrons
1
2016
6
0.030
 Why?
Tissue Distribution
1
2017
175
0.030
 Why?
Consensus
1
2018
195
0.030
 Why?
Hospital Communication Systems
1
2016
5
0.030
 Why?
Coitus
1
2016
18
0.030
 Why?
Failure to Thrive
1
2016
19
0.030
 Why?
Salvage Therapy
1
2017
137
0.030
 Why?
Anastomosis, Surgical
1
2016
69
0.030
 Why?
Radiometry
1
2017
125
0.030
 Why?
Creatinine
1
2016
156
0.030
 Why?
Early Detection of Cancer
1
2018
185
0.030
 Why?
Molecular Imaging
1
2016
28
0.030
 Why?
Cyclin-Dependent Kinase 4
1
2015
10
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2015
12
0.030
 Why?
Operative Time
1
2016
76
0.030
 Why?
Genes, erbB-1
1
2015
9
0.030
 Why?
Tape Recording
1
2015
7
0.030
 Why?
Fever
1
2016
113
0.030
 Why?
Socioeconomic Factors
2
2011
609
0.030
 Why?
Learning Curve
1
2015
20
0.030
 Why?
Groin
1
2015
16
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Oncology Service, Hospital
1
2014
14
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2015
49
0.030
 Why?
Vinblastine
1
2014
22
0.030
 Why?
Europe
1
2014
90
0.030
 Why?
North America
1
2014
75
0.030
 Why?
Regression Analysis
1
2015
400
0.030
 Why?
Incontinence Pads
1
2014
2
0.030
 Why?
Kidney Failure, Chronic
1
2016
205
0.030
 Why?
In Situ Hybridization
1
2014
69
0.030
 Why?
Personal Satisfaction
1
2014
74
0.030
 Why?
Amino Acid Substitution
1
2014
79
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2018
853
0.030
 Why?
Gene Dosage
1
2014
73
0.030
 Why?
Ultrasonography
1
2016
416
0.030
 Why?
Methotrexate
1
2014
76
0.030
 Why?
United States Department of Veterans Affairs
1
2015
291
0.030
 Why?
Anxiety
1
2016
305
0.030
 Why?
Papillomaviridae
1
2014
102
0.030
 Why?
Survivors
1
2014
121
0.030
 Why?
Dysuria
1
2013
1
0.030
 Why?
Anesthesiology
1
2014
37
0.030
 Why?
Cluster Analysis
1
2014
236
0.030
 Why?
Prevalence
1
2016
1016
0.030
 Why?
Sequence Analysis, DNA
1
2014
220
0.030
 Why?
Intention to Treat Analysis
1
2013
30
0.030
 Why?
Valsalva Maneuver
1
2013
10
0.030
 Why?
Gene Expression Profiling
1
2018
1099
0.020
 Why?
Stents
1
2016
368
0.020
 Why?
Diagnostic Tests, Routine
1
2013
31
0.020
 Why?
Health Services Research
1
2013
153
0.020
 Why?
Paclitaxel
1
2013
91
0.020
 Why?
Doxorubicin
1
2014
246
0.020
 Why?
Confidence Intervals
1
2013
158
0.020
 Why?
Neutropenia
1
2013
113
0.020
 Why?
Antibiotics, Antineoplastic
1
2013
83
0.020
 Why?
Survival Analysis
1
2014
656
0.020
 Why?
Thrombocytopenia
1
2013
93
0.020
 Why?
Attitude of Health Personnel
1
2015
358
0.020
 Why?
Angiomyolipoma
1
2012
9
0.020
 Why?
Unnecessary Procedures
1
2012
20
0.020
 Why?
Neoplasm, Residual
1
2013
169
0.020
 Why?
Tertiary Care Centers
1
2012
83
0.020
 Why?
Pilot Projects
1
2014
725
0.020
 Why?
Neoplasms, Multiple Primary
1
2012
44
0.020
 Why?
Biopsy, Fine-Needle
1
2012
104
0.020
 Why?
Patient Positioning
1
2011
31
0.020
 Why?
Urination Disorders
1
2010
23
0.020
 Why?
Disease Management
1
2012
185
0.020
 Why?
Organ Size
1
2010
226
0.020
 Why?
Comorbidity
1
2012
637
0.020
 Why?
Health Status Disparities
1
2011
218
0.020
 Why?
Intraoperative Period
1
2007
46
0.020
 Why?
Erythrocyte Transfusion
1
2006
52
0.020
 Why?
Costs and Cost Analysis
1
2006
94
0.020
 Why?
Decision Trees
1
2005
23
0.010
 Why?
Portal System
1
2005
17
0.010
 Why?
Collateral Circulation
1
2005
38
0.010
 Why?
Hypertension, Portal
1
2005
23
0.010
 Why?
Reoperation
1
2006
463
0.010
 Why?
Blood Transfusion
1
2005
126
0.010
 Why?
Short Bowel Syndrome
1
2004
17
0.010
 Why?
Necrosis
1
2004
169
0.010
 Why?
Liver Transplantation
1
2005
172
0.010
 Why?
Polymorphism, Genetic
1
2002
184
0.010
 Why?
Genetic Markers
1
2002
108
0.010
 Why?
Statistics, Nonparametric
1
2002
199
0.010
 Why?
Base Sequence
1
2002
632
0.010
 Why?
Polymerase Chain Reaction
1
2002
458
0.010
 Why?
Molecular Sequence Data
1
2002
778
0.010
 Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (434) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department